 Bringing science into the public eye also coincided with the rapid rate at which recombinant DNA technology entered the industrial world.Because of the practical applications of the technology, funding for research using it started coming more from the private sector and less from the public sector.In addition, many molecular biologists who once confined themselves to academia, developed ties with private industry as equity owners, corporate executives and consultants.